Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01870544 · ClinicalTrials.gov registry record · Phase 1
Does Weight Loss Surgery and Probiotic Supplementation Lead to a "Lean" Gut Microbiota?
A Phase 1 study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT01870544 is a Phase 1 study that has completed, run by Tufts Medical Center. The registered enrollment target is 18 participants.
The verdict
NCT01870544, a Phase 1 study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of the weight-loss study is to characterize the effect of LGG supplementation on the relative abundance of phyla in the gut microbiota of patients undergoing gastric bypass and sleeve gastrectomy surgery, and to elucidate a relationship between the gut microbiota pattern and the degree of weight-loss post-surgery. The investigators hypothesize that LGG administration will result in a "leaner" pattern of gut microbiota that will lead to higher weight loss at 3 months post-surgery.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Lactobacillus Rhamnosus GG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01870544
The ClinicalTrials.gov registry entry for NCT01870544 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01870544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01870544 about?
NCT01870544 is a clinical study titled "Does Weight Loss Surgery and Probiotic Supplementation Lead to a "Lean" Gut Microbiota?". The purpose of the weight-loss study is to characterize the effect of LGG supplementation on the relative abundance of phyla in the gut microbiota of patients undergoing gastric bypass and sleeve gastrectomy surgery, and to elucidate a relationship between the gut microbiota pattern and the degree o...
What is the current status of trial NCT01870544?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2013-09. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01870544?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Lactobacillus Rhamnosus GG (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01870544?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.